◼ Archived
Business
🔮 Newsylist predicts: fades by tomorrow medium confidence — graded ✓ correct
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths
3sources
3articles
1velocity
+0%since first seen
58d agofirst detected
Text:
🤖 AI Dossier
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The reporting (3)
-
-
-
Novartis Halts Eight CAR-T Trials After Three Patient Deaths finance.biggo.com · 58d ago broke it first
📊 AUDIENCE & LONGEVITY PULSE
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Related trends
↑ Rising
Business
2 Reasons Why GE HealthCare Stock Is Climbing After Earnings
🔥 Breakout ↑ Rising
Business
Bud Light Brewer AB InBev Says Alternative Drinks Help Steady Slide in Beer Volumes
🔥 Breakout ↑ Rising
Business
The Beleaguered Chip Sellers Getting Their Revenge on Apple
🔥 Breakout ↑ Rising
Business
Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
▲ Peaking
Business
Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand
▲ Peaking
Business